Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OTLC | AZN | AMGN | GILD | BMY |
| Company | Oncotelic Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0700 | 187.07 | 365.73 | 146.50 | 58.91 |
| High | 0.0716 | 190.67 | 374.90 | 150.50 | 60.56 |
| Low | 0.0700 | 186.58 | 365.00 | 145.87 | 58.00 |
| Latest | 0.0706 | 187.16 | 367.80 | 149.37 | 59.52 |
| Change | -0.0015 | -0.29 | +1.60 | +3.14 | +1.90 |
| % Change | -2.08% | -0.15% | +0.44% | +2.15% | +3.30% |
| Volume | 39,600 | 3,380,500 | 4,007,300 | 9,143,000 | 23,929,600 |
| 20-Day Average Volume | 149,035 | 8,984,855 | 3,034,330 | 8,077,560 | 13,228,175 |
| Previous Close | 0.0721 | 187.45 | 366.20 | 146.23 | 57.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0771 | 112.12 | 340.36 | 132.92 | 55.69 |
| 20-Day Raw Stochastic | 25.44% | 94.57% | 87.12% | 96.37% | 85.17% |
| 20-Day Relative Strength | 42.54 | 88.10 | 66.58 | 75.02 | 68.91 |
| Weighted Alpha | +34.09 | +68.67 | +33.17 | +61.59 | +17.14 |
| Today's Opinion | 24% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 24% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 40% Buy | 100% Buy | 88% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.81% since 01/29/26 | +102.14% since 01/29/26 | +7.25% since 01/29/26 | +7.04% since 01/29/26 | +9.65% since 01/29/26 |
| Low | 0.0700 on 02/05/26 | 92.46 on 01/30/26 | 338.07 on 01/30/26 | 138.65 on 01/30/26 | 54.33 on 01/30/26 |
| High | 0.0792 on 01/30/26 | 192.79 on 02/02/26 | 374.90 on 02/05/26 | 150.50 on 02/05/26 | 60.56 on 02/05/26 |
| 1-Month | |||||
| %Chg | -9.25% since 01/05/26 | +105.17% since 01/05/26 | +14.68% since 01/05/26 | +26.26% since 01/05/26 | +12.17% since 01/05/26 |
| Low | 0.0633 on 01/23/26 | 89.04 on 01/21/26 | 318.83 on 01/06/26 | 118.22 on 01/06/26 | 53.15 on 01/06/26 |
| High | 0.0940 on 01/07/26 | 192.79 on 02/02/26 | 374.90 on 02/05/26 | 150.50 on 02/05/26 | 60.56 on 02/05/26 |
| 3-Month | |||||
| %Chg | -32.76% since 11/05/25 | +130.63% since 11/05/25 | +14.99% since 11/05/25 | +21.86% since 11/05/25 | +28.08% since 11/05/25 |
| Low | 0.0633 on 01/23/26 | 83.37 on 11/06/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 0.1070 on 11/06/25 | 192.79 on 02/02/26 | 374.90 on 02/05/26 | 150.50 on 02/05/26 | 60.56 on 02/05/26 |
| 6-Month | |||||
| %Chg | +38.70% since 08/05/25 | +151.29% since 08/05/25 | +22.57% since 08/05/25 | +32.82% since 08/05/25 | +29.81% since 08/05/25 |
| Low | 0.0350 on 08/08/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.1100 on 10/22/25 | 192.79 on 02/02/26 | 374.90 on 02/05/26 | 150.50 on 02/05/26 | 60.56 on 02/05/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 31,247 | 290,267,936 | 198,053,312 | 185,320,384 | 121,168,016 |
| Shares Outstanding, K | 442,597 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -4,520,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -1,050,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | -0.66 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 11/17/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/21/26 | 02/10/26 | 05/07/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.51 | 16.76 | 17.85 | 8.78 |